BREAST CANCER (LOCALLY ADVANCED OR METASTATIC)
Clinical trials for BREAST CANCER (LOCALLY ADVANCED OR METASTATIC) explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER (LOCALLY ADVANCED OR METASTATIC) trials appear
Sign up with your email to follow new studies for BREAST CANCER (LOCALLY ADVANCED OR METASTATIC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug INV-6452 targets Hard-to-Treat breast cancers
Disease control Recruiting nowThis study tests an experimental drug called INV-6452 in adults with advanced breast cancer (HR+/HER2-) or other solid tumors that have stopped responding to standard treatments. The goal is to find the safest dose and see if the drug can shrink tumors. About 201 participants wil…
Matched conditions: BREAST CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Ionova Life Sciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Engineered immune cells take on Hard-to-Treat breast cancers
Disease control Recruiting nowThis study tests a new treatment using specially engineered immune cells (CAR-NK cells) to fight advanced breast cancer, including HER2-positive and triple-negative types. About 60 adults whose cancer has not responded to standard treatments will receive cells tailored to their t…
Matched conditions: BREAST CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: PHASE1, PHASE2 • Sponsor: Beijing Biotech • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Immune cell therapy takes on Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new treatment called EBNK-001, made from donor immune cells (natural killer cells), in people with advanced solid tumors that have not responded to standard therapies. Participants receive the cells after chemotherapy to prepare the body, along with low-dose in…
Matched conditions: BREAST CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: PHASE1, PHASE2 • Sponsor: Essen Biotech • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New shot SH009 targets tough cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new drug called SH009 in people with advanced solid tumors (like liver, lung, breast, or stomach cancer) that have not responded to standard treatments. The main goals are to see if the drug shrinks tumors and to check its safety. About 150 adults w…
Matched conditions: BREAST CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: PHASE1 • Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
AI phone app aims to ease cancer treatment side effects
Symptom relief Recruiting nowThis pilot study is testing whether an AI-powered smartphone app called ASSIST can help people with breast cancer, lymphoma, or colorectal cancer manage symptoms while on systemic therapy. Sixty participants will either use the app for 12 weeks or receive standard care. The main …
Matched conditions: BREAST CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: NA • Sponsor: Patrick C. Johnson, MD • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Tattoo marks could help surgeons save more breasts in cancer fight
Knowledge-focused Recruiting nowThis study tests whether tattooing the skin over a breast tumor before chemotherapy can help surgeons later remove the cancer completely while saving as much healthy breast tissue as possible. Thirty women with breast cancer will get their tumor edges marked with tattoo ink, then…
Matched conditions: BREAST CANCER (LOCALLY ADVANCED OR METASTATIC)
Phase: NA • Sponsor: All India Institute of Medical Sciences, Bhubaneswar • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC